GGrantIndex
Sort

15,440 grants matching organoids

Cancer patient on a chip

$511,615
Gordana Vunjak-Novakovic · Columbia University Health Sciences · R01 · FY2023 · CA

Cancer patient on a chip

$511,615
Gordana Vunjak-Novakovic · Columbia University Health Sciences · R01 · FY2022 · CA

Viscotaxis: Novel cell migration mechanisms regulated by microenvironmental viscosity

$511,567
Konstantinos Konstantopoulos · Johns Hopkins University · R01 · FY2021 · CA

Intestinal and Milk Glycan Expression in Restriction of Neonatal Infection

$511,544
Mary Kolb Estes · Baylor College Of Medicine · R01 · FY2014 · AI

Targeting replication stress to engage DNA sensing STING pathway derived anti-tumor immunity to improve the therapeutic outcomes in uterine cancer

$511,431
Jean Zhao · Dana-Farber Cancer Inst · P01 · FY2024 · CA

Dissecting the role of Notch signaling in the pancreatic cancer microenvironment.

$511,394
Marina Pasca Di Magliano · University Of Michigan At Ann Arbor · R01 · FY2023 · CA

Genetic analysis of mucin utilization by Akkermansia muciniphila and its impact on host physiology

$511,305
Raphael H. Valdivia · Duke University · R01 · FY2019 · AI

Genetic analysis of mucin utilization by Akkermansia muciniphila and its impact on host physiology

$511,305
Raphael H. Valdivia · Duke University · R01 · FY2020 · AI

Engineering multi-lineage human inner ear organoids

$511,285
Karl Russell Koehler · Boston Children'S Hospital · R01 · FY2022 · DC

Engineering multi-lineage human inner ear organoids

$511,285
Karl Russell Koehler · Boston Children'S Hospital · R01 · FY2023 · DC

Metabolic barriers to T cell activation in clear cell renal cell carcinoma

$511,194
Jeffrey C Rathmell · Vanderbilt University Medical Center · R01 · FY2024 · CA

Bacterial biosensors for the prevention of gastrointestinal cancers

$511,174
Jeff M Hasty · University Of California, San Diego · R01 · FY2025 · CA

Decreased SRD5A2 and Alternative Estrogen Signaling in Prostatic Cell Survival

$511,084
Zongwei Wang · Beth Israel Deaconess Medical Center · R01 · FY2024 · DK

Therapeutic efficacy of the CRL inhibitor MLN4924 in NF2 mutant mesothelioma

$510,996
Filippo G Giancotti · University Of Tx Md Anderson Can Ctr · R01 · FY2017 · CA

Developing Functional Human Cell Models to Study Initiation and Progression of Prostate Cancer between AA and EA men

$510,952
Xuefeng Liu · Ohio State University · R01 · FY2024 · CA

Targeting PP4 to improve ovarian cancer response to immunotherapy

$510,892
Marion Curtis · Mayo Clinic Arizona · R37 · FY2023 · CA

Bio-MAPS: BioMolecular-Array Patterns for Precision Differentiation of Intestinal Stem Cells

$510,838
Michael Daniele · North Carolina State University · · FY2021 · ENG

Gene therapy for GERD-associated esophageal epithelial barrier dysfunction

$510,795
David A Dean · University Of Rochester · R01 · FY2021 · DK

The Role of the Microbiome and Notch Signaling in Esophageal Adenocarcinoma

$510,755
Julian Abrams · Columbia University Health Sciences · R01 · FY2022 · CA

Nrf2 Regulation of Ductal Pancreatic Cancer Etiology and Treatment Response

$510,684
David Tuveson · Cold Spring Harbor Laboratory · R01 · FY2017 · CA

H. Pylori Relationship to Digestive Diseases and Cancer

$510,479
Richard M Peek · Vanderbilt University Medical Center · R01 · FY2023 · CA

Project 2: Reversing resistance caused by lineage plasticity through epigenetic therapy

$510,416
Yu Chen · Sloan-Kettering Inst Can Research · U54 · FY2020 · CA

Mechanisms of Homeodomain Transcription Factor Specificity

$510,390
Brian Gebelein · Cincinnati Childrens Hosp Med Ctr · R35 · FY2025 · GM

Engineering Heterocellular Human Skeletal Muscle Tissues to Recreate and Study Native Stem Cell Niche Function

$510,389
Nenad Bursac · Duke University · R01 · FY2025 · AR

Neoadjuvant Neratinib in Stage I-III HER2-mutated Lobular Breast Cancer

$510,310
Laura Carpin Kennedy · Vanderbilt University Medical Center · R01 · FY2023 · CA